Report Code: A01027 | Pages: NA | Jul 2023 | 3602 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Asia Pacific Home Healthcare Market
Request Now !The market for home healthcare involves broad range of the medical devices, which help the patients to diagnose or treat various chronic diseases. The home healthcare devices play a crucial role in providing the cost-effective healthcare treatments to patients. These devices provide beneficial business opportunities owing to the rising acceptance, technological advancements and cost-effective alternatives of these devices as compared to the other treatment modalities (hospital treatment). The Asia-Pacific home healthcare market is growing at a promising CAGR due to the increasing aging population and rising number of individuals diagnosed with the chronic illness such as cardiac disorders, diabetes and various respiratory diseases. In addition, the Asia-Pacific home healthcare devices are still at the nascent stage in developing regions such as India and witnessing the lucrative growth rate during the analysis period. These factors would fuel the requirements of home healthcare devices during the study period, and hence will boost the market growth. However, the high cost coupled with the reimbursement issues related with adoption of home healthcare devices would restrain the market growth.
The Asia-Pacific home healthcare market is segmented on the basis of device types, end users and geography. Based on device types, the market is segmented into diagnostics and monitoring devices, mobility assist devices, therapeutic home healthcare devices and medical supplies. Based on the end users, the Asia-Pacific home healthcare market is categorized into pediatrics, geriatrics and others. Geographically, the Asia-Pacific home healthcare market is segmented into China, Japan, India, Australia and others. Emerging economies such as India, China, Singapore and Malaysia are the potential geographies for market expansion due to improving healthcare standards. These economies have a large presence of domestic manufacturers of home healthcare devices, which contribute to an increase in the market competition for multinational giants by adopting the strategy of price penetration.
Companies profiled in this report are Bayer AG, Cardinal Health, Inc., Abbott Laboratories, GE Healthcare, Gentiva Health Services, Inc., Johnson & Johnson Services, Inc., Invacare Corporation, 3M Health Care, Phillips Healthcare, F. Hoffmann-La Roche Ltd., Omron Healthcare, Inc. and Medtronic Inc.
KEY TAKE AWAYS
The Asia-Pacific home healthcare market is segmented into device types, end users and geography segments.
Asia Pacific Home Healthcare Market Report Highlights
Aspects | Details |
---|---|
By DEVICE TYPE |
|
By END USERS |
|
By Region |
|
Key Market Players | GE Healthcare, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Gentiva Health Services, Inc., 3M Health Care, Phillips Healthcare, Bayer AG, Abbott Laboratories, Invacare Corporation, Cardinal Health, Inc., Medtronic Inc., Omron Healthcare, Inc. |
Start reading.
This Report and over 53,643+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers